US5427940A
(en)
*
|
1991-06-03 |
1995-06-27 |
Board Of Regents, The University Of Texas System |
Engineered cells producing insulin in response to glucose
|
US5744327A
(en)
*
|
1990-02-20 |
1998-04-28 |
Board Of Regents, The University Of Texas System |
Methods for producing insulin in response to non-glucose secretagogues
|
US5792656A
(en)
*
|
1991-06-03 |
1998-08-11 |
Board Of Regents, The University Of Texas System |
Methods of preparing genetically engineered cells that produce insulin in response to glucose
|
US5571787A
(en)
|
1993-07-30 |
1996-11-05 |
Myelos Corporation |
Prosaposin as a neurotrophic factor
|
US5908623A
(en)
*
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
AU7568094A
(en)
*
|
1993-08-12 |
1995-03-14 |
Cytotherapeutics, Inc. |
Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
US5550050A
(en)
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US5670347A
(en)
|
1994-05-11 |
1997-09-23 |
Amba Biosciences Llc |
Peptide-mediated gene transfer
|
US5858747A
(en)
*
|
1994-07-20 |
1999-01-12 |
Cytotherapeutics, Inc. |
Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
|
WO1996035446A1
(en)
*
|
1995-05-12 |
1996-11-14 |
The Rockefeller University |
Treatment of alzheimer disease by modulation of synapsins
|
IN181898B
(de)
*
|
1995-06-07 |
1998-10-24 |
Cytotherapeutics Inc |
|
US7279313B2
(en)
*
|
1995-09-15 |
2007-10-09 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
US7364894B2
(en)
*
|
1995-09-15 |
2008-04-29 |
Centelion |
Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
|
FR2738842B1
(fr)
*
|
1995-09-15 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
AU7204996A
(en)
*
|
1995-10-02 |
1997-04-28 |
Cytotherapeutics, Inc. |
Method for treating amyotrophic lateral sclerosis
|
US5855613A
(en)
*
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
US5929041A
(en)
*
|
1996-02-23 |
1999-07-27 |
Amgen Inc. |
Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
|
US5837681A
(en)
*
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US7297331B2
(en)
*
|
1996-04-03 |
2007-11-20 |
The Rogosin Institute |
Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
|
US6224912B1
(en)
|
1996-04-03 |
2001-05-01 |
The Rogo Institute |
Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
|
US6210664B1
(en)
|
1996-04-08 |
2001-04-03 |
New York University Medical Center |
Method for gene transfer to the central nervous system
|
AU2674097A
(en)
*
|
1996-04-17 |
1997-11-07 |
Cytotherapeutics, Inc. |
Method and device for delivery of apoptosis-inducing molecules
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
US5945100A
(en)
*
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
US6054142A
(en)
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
US6150164A
(en)
*
|
1996-09-30 |
2000-11-21 |
The Regents Of The University Of Michigan |
Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
|
US6156728A
(en)
*
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
EP1010432A4
(de)
*
|
1997-01-23 |
2004-03-10 |
Sumitomo Pharma |
Heilmittel für diabetes
|
US5844077A
(en)
*
|
1997-04-28 |
1998-12-01 |
Cytotherapeutics, Inc. |
Use of conantokins for producing analgesia or for neuroprotection
|
US6042579A
(en)
*
|
1997-04-30 |
2000-03-28 |
Medtronic, Inc. |
Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
|
AU7165998A
(en)
*
|
1997-05-30 |
1998-12-30 |
Amgen, Inc. |
Neurotrophic factor receptors
|
AU7977198A
(en)
|
1997-06-17 |
1999-01-04 |
University Technology Corporation |
Neural transplantation for treating neurological disease
|
US6167888B1
(en)
*
|
1997-06-30 |
2001-01-02 |
The Regents Of The University Of California |
Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal
|
ZA986077B
(en)
|
1997-07-09 |
2000-01-10 |
Genentech Inc |
ErbB4 receptor-specific neuregulin related ligands and uses therefor.
|
US6121415A
(en)
|
1997-07-09 |
2000-09-19 |
Genentech, Inc. |
ErbB4 receptor-specific neuregolin related ligands and uses therefor
|
US6469311B1
(en)
|
1997-07-16 |
2002-10-22 |
Molecular Devices Corporation |
Detection device for light transmitted from a sensed volume
|
US6071748A
(en)
|
1997-07-16 |
2000-06-06 |
Ljl Biosystems, Inc. |
Light detection device
|
US6994856B1
(en)
|
1997-07-24 |
2006-02-07 |
Genentech, Inc. |
ErbB4 receptor-specific neuregulin related ligands and uses therefor
|
US6043221A
(en)
|
1997-07-30 |
2000-03-28 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neuturin protein product
|
US6042909A
(en)
*
|
1997-09-03 |
2000-03-28 |
Circe Biomedical, Inc. |
Encapsulation device
|
US7745142B2
(en)
|
1997-09-15 |
2010-06-29 |
Molecular Devices Corporation |
Molecular modification assays
|
US6326605B1
(en)
|
1998-02-20 |
2001-12-04 |
Ljl Biosystems, Inc. |
Broad range light detection system
|
US6576476B1
(en)
|
1998-09-02 |
2003-06-10 |
Ljl Biosystems, Inc. |
Chemiluminescence detection method and device
|
WO2000006991A2
(en)
|
1998-07-27 |
2000-02-10 |
Ljl Biosystems, Inc. |
Apparatus and methods for spectroscopic measurements
|
WO2000050877A1
(en)
|
1999-02-23 |
2000-08-31 |
Ljl Biosystems, Inc. |
Frequency-domain light detection device
|
WO2000006990A2
(en)
|
1998-07-27 |
2000-02-10 |
Ljl Biosystems, Inc. |
Apparatus and methods for time-resolved spectroscopic measurements
|
US6825921B1
(en)
|
1999-11-10 |
2004-11-30 |
Molecular Devices Corporation |
Multi-mode light detection system
|
US6297018B1
(en)
|
1998-04-17 |
2001-10-02 |
Ljl Biosystems, Inc. |
Methods and apparatus for detecting nucleic acid polymorphisms
|
US6156729A
(en)
|
1997-10-15 |
2000-12-05 |
California Institute Of Technology |
Leukemia inhibitory factor for use in modulating inflammation and pain
|
US6485901B1
(en)
*
|
1997-10-27 |
2002-11-26 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to linear beacons
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
JP2002506830A
(ja)
|
1998-03-13 |
2002-03-05 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
治療的ケモカイン受容体アンタゴニスト
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
US6277820B1
(en)
|
1998-04-09 |
2001-08-21 |
Genentech, Inc. |
Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
|
US6303136B1
(en)
|
1998-04-13 |
2001-10-16 |
Neurotech S.A. |
Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
|
WO1999057248A1
(en)
*
|
1998-04-30 |
1999-11-11 |
President And Fellows Of Harvard College |
Induction of neuronal regeneration
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
AU4981999A
(en)
*
|
1998-07-24 |
2000-02-14 |
Allegheny University Of The Health Sciences |
Allogeneic cellular immunogens useful as cancer vaccines
|
US20020115213A1
(en)
*
|
1998-08-14 |
2002-08-22 |
Northeastern Ohio Universities Of Medicine |
Engraftable neural progenitor & stem cells for brain tumor therapy
|
HUP0103994A3
(en)
*
|
1998-09-09 |
2004-03-01 |
Myelos Corp San Diego |
Method of stimulating prosaposin receptor activity
|
IL141865A0
(en)
*
|
1998-09-09 |
2002-03-10 |
Myelos Corp |
Method of stimulating prosaposin receptor activity
|
US6344541B1
(en)
*
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6156514A
(en)
*
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
NZ551331A
(en)
|
1999-02-03 |
2008-08-29 |
Amgen Inc |
Methods using polypeptides involved in immune response
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
US6713293B1
(en)
|
1999-02-08 |
2004-03-30 |
Friedrich Grummt |
Encapsulated cells containing an amplified expression vector as a drug delivery device
|
AU772153B2
(en)
*
|
1999-02-12 |
2004-04-08 |
Molecular Insight Pharmaceuticals, Inc. |
Matrices for drug delivery and methods for making and using the same
|
US6903244B1
(en)
|
1999-02-26 |
2005-06-07 |
University Of Utah Research Foundation |
Mice which are +/− or −/− for the elastin gene as models for vascular disease
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6365385B1
(en)
|
1999-03-22 |
2002-04-02 |
Duke University |
Methods of culturing and encapsulating pancreatic islet cells
|
US6303355B1
(en)
|
1999-03-22 |
2001-10-16 |
Duke University |
Method of culturing, cryopreserving and encapsulating pancreatic islet cells
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
ATE514772T1
(de)
|
1999-08-05 |
2011-07-15 |
Abt Holding Co |
Multipotente erwachsene stammzellen und verfahren zu deren isolierung
|
US8147824B2
(en)
|
1999-08-05 |
2012-04-03 |
Athersys, Inc. |
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US6878543B1
(en)
|
1999-10-25 |
2005-04-12 |
Nsgene Sa |
Cultures of GFAP+ nestin+ cells that differentiate to neurons
|
US6267954B1
(en)
*
|
1999-11-24 |
2001-07-31 |
Universite De Paris V Rene-Descartes |
Intraocular transplantation of encapsulated cells
|
US7060676B2
(en)
*
|
1999-12-20 |
2006-06-13 |
Trustees Of Tufts College |
T. cruzi-derived neurotrophic agents and methods of use therefor
|
US6458118B1
(en)
|
2000-02-23 |
2002-10-01 |
Medtronic, Inc. |
Drug delivery through microencapsulation
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US7378098B2
(en)
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
US20050059584A1
(en)
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
US7368425B2
(en)
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
US6375972B1
(en)
*
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
CA2413547A1
(en)
*
|
2000-06-28 |
2002-01-03 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
PT2077279E
(pt)
|
2000-06-28 |
2012-09-14 |
Amgen Inc |
Moléculas do receptor de linfopoietina estromal tímica e suas utilizações
|
US6538010B1
(en)
*
|
2000-11-08 |
2003-03-25 |
Research Triangle Institute |
Compounds and methods for promoting smoking cessation
|
JP4236925B2
(ja)
|
2000-11-28 |
2009-03-11 |
アムジエン・インコーポレーテツド |
免疫応答に関与する新規ポリペプチド
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
KR20030096381A
(ko)
*
|
2001-05-11 |
2003-12-24 |
오쏘-맥네일 파머슈티칼 인코퍼레이티드 |
동물에 사용하기 위한 면역 조절장치
|
NZ530332A
(en)
*
|
2001-06-22 |
2005-06-24 |
Univ Catholique De Louvaine |
Hydrogel beads or capsules as artificial media for insects oviposition and rearing of endoparasitoids
|
EP1281767A3
(de)
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren
|
US7332330B2
(en)
|
2001-09-11 |
2008-02-19 |
Renamed Biologics, Inc. |
Device for maintaining vascularization near an implant
|
US7981863B2
(en)
*
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
DE10164039A1
(de)
*
|
2001-12-28 |
2003-07-10 |
Nmi Univ Tuebingen |
Implantierbare Vorrichtung und deren Verwendung
|
US7662924B2
(en)
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7442546B2
(en)
*
|
2002-03-15 |
2008-10-28 |
The Regents Of The University Of Michigan |
Method of modulating inflammatory response
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
PL212661B1
(pl)
|
2002-05-16 |
2012-11-30 |
Absorber |
Sposób izolacji komórki prekursorowej sródblonka
|
EP1369491A1
(de)
*
|
2002-06-05 |
2003-12-10 |
Aladar A. Szalay |
Lichtemittierende Mikroorganismen und Zellen für die Diagnose und Therapie von Krankheiten assoziiert mit Wunden oder entzündetem Gewebe
|
US20030228261A1
(en)
*
|
2002-06-05 |
2003-12-11 |
Aladar Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
NZ537072A
(en)
*
|
2002-06-18 |
2006-12-22 |
Eisai Co Ltd |
Primary cultured adipocytes for gene therapy to which a foreign gene has been transferred
|
US7276057B2
(en)
*
|
2002-09-06 |
2007-10-02 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
|
US7328068B2
(en)
*
|
2003-03-31 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
|
US7328069B2
(en)
*
|
2002-09-06 |
2008-02-05 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
|
US7369894B2
(en)
*
|
2002-09-06 |
2008-05-06 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
|
US7427280B2
(en)
|
2002-09-06 |
2008-09-23 |
Medtronic, Inc. |
Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7605249B2
(en)
*
|
2002-11-26 |
2009-10-20 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7618948B2
(en)
*
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
AU2002952993A0
(en)
|
2002-11-29 |
2002-12-12 |
The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland |
Therapeutic and diagnostic agents
|
US20040230182A1
(en)
*
|
2002-12-27 |
2004-11-18 |
Medtronic, Inc. |
Drug delivery through encapsulation
|
US7732591B2
(en)
*
|
2003-11-25 |
2010-06-08 |
Medtronic, Inc. |
Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
|
US7994149B2
(en)
|
2003-02-03 |
2011-08-09 |
Medtronic, Inc. |
Method for treatment of Huntington's disease through intracranial delivery of sirna
|
WO2004094592A2
(en)
|
2003-04-18 |
2004-11-04 |
Biogen Idec Ma Inc. |
Polymer-conjugated glycosylated neublastin
|
US7459152B2
(en)
*
|
2003-04-23 |
2008-12-02 |
Rush University Medical Center |
Erythropoietin administration to improve graft survival
|
DE602004023832D1
(de)
|
2003-05-16 |
2009-12-10 |
Univ Laval |
Cns chlorid-modulierung und verwendung derselben
|
AU2004245175C1
(en)
|
2003-06-10 |
2010-03-18 |
Biogen Ma Inc. |
Improved secretion of neublastin
|
DE602004018927D1
(de)
|
2003-06-18 |
2009-02-26 |
Genelux Corp |
Modifizierte rekombinante vacciniaviren, verwendungen davon
|
WO2005020677A1
(en)
|
2003-08-29 |
2005-03-10 |
The Walter And Eliza Hall Institute Of Medical Research |
Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening
|
BRPI0415563A
(pt)
|
2003-10-20 |
2007-01-02 |
Nsgene As |
método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional
|
NZ547767A
(en)
|
2003-12-24 |
2010-05-28 |
Inst Medical W & E Hall |
Therapeutic agents and uses therefor
|
WO2005068498A2
(en)
*
|
2004-01-19 |
2005-07-28 |
Nsgene A/S |
Human therapeutic cells secreting nerve growth factor
|
US8467875B2
(en)
|
2004-02-12 |
2013-06-18 |
Medtronic, Inc. |
Stimulation of dorsal genital nerves to treat urologic dysfunctions
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
DE602005014354D1
(de)
|
2004-03-30 |
2009-06-18 |
Nsgene As |
Therapeutische verwendung des wachstumsfaktors nsg33
|
EP1766389A4
(de)
|
2004-05-12 |
2008-08-27 |
Inst Medical W & E Hall |
Zellisolierungsverfahren
|
WO2005112959A2
(en)
|
2004-05-17 |
2005-12-01 |
Regents Of The University Of Minnesota |
Use of umbilical cord blood stem cells to treat ischemic event
|
WO2006013462A2
(en)
*
|
2004-07-30 |
2006-02-09 |
Nsgene A/S |
Growth factors nsg28, nsg30, and nsg32
|
NZ553420A
(en)
|
2004-08-19 |
2010-02-26 |
Biogen Idec Inc |
Refolding transforming growth factor beta family proteins
|
KR20110126732A
(ko)
|
2004-08-19 |
2011-11-23 |
바이오겐 아이덱 엠에이 인코포레이티드 |
뉴블라스틴 변형체
|
US20060099193A1
(en)
*
|
2004-10-22 |
2006-05-11 |
Ikuko Sugaya |
Methods and materials for suppressing pain
|
CA2603391A1
(en)
|
2005-04-01 |
2006-10-05 |
Nsgene A/S |
A human immortalised neural precursor cell line
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
KR101504622B1
(ko)
|
2005-04-29 |
2015-03-20 |
에이전시 포 사이언스, 테크놀로지 앤드 리서치 |
고차가지구조 고분자 및 그들의 응용
|
US20060257368A1
(en)
*
|
2005-05-03 |
2006-11-16 |
Clemson University |
Devices and methods for improved viability of cells
|
CA2606858A1
(en)
*
|
2005-05-03 |
2006-11-09 |
Veterinarmedizinische Universitat Wien |
Permeable capsules
|
US7902352B2
(en)
*
|
2005-05-06 |
2011-03-08 |
Medtronic, Inc. |
Isolated nucleic acid duplex for reducing huntington gene expression
|
WO2006121960A2
(en)
*
|
2005-05-06 |
2006-11-16 |
Medtronic, Inc. |
Methods and sequences to suppress primate huntington gene expression
|
WO2006122550A2
(en)
|
2005-05-17 |
2006-11-23 |
Nsgene A/S |
Storage container comprising an implantable therapy system
|
US20090169523A1
(en)
|
2005-06-13 |
2009-07-02 |
Catherine Verfaillie |
Hsc self-renewal
|
CN101248177B
(zh)
|
2005-06-24 |
2012-09-05 |
沃尔特及伊莱萨霍尔医学研究院 |
治疗性促凋亡bh3样分子和用于产生和/或选择它的方法
|
US9133517B2
(en)
*
|
2005-06-28 |
2015-09-15 |
Medtronics, Inc. |
Methods and sequences to preferentially suppress expression of mutated huntingtin
|
US20080280843A1
(en)
*
|
2006-05-24 |
2008-11-13 |
Van Bilsen Paul |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
US8357666B2
(en)
|
2005-08-01 |
2013-01-22 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through RNA interference
|
CA2621083C
(en)
|
2005-08-30 |
2017-04-11 |
University Of Miami |
Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
|
US9388382B2
(en)
*
|
2005-10-05 |
2016-07-12 |
The Board Of Trustees Of The University Of Illinois |
Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
|
CA2627543A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Ns Gene A/S |
Implantable biocompatible immttnoisolatory vehicle for delivery of gdnf
|
US10117900B2
(en)
*
|
2005-11-09 |
2018-11-06 |
Athersys, Inc. |
MAPC treatment of brain injuries and diseases
|
US11000546B2
(en)
|
2005-11-09 |
2021-05-11 |
Athersys, Inc. |
Immunomodulatory properties of MAPCs and uses thereof
|
CA2629715C
(en)
|
2005-11-18 |
2016-05-03 |
Glenmark Pharmaceuticals S.A. |
Anti-alpha2 integrin antibodies and their uses
|
WO2007078922A2
(en)
|
2005-12-30 |
2007-07-12 |
Neurotech Usa Inc. |
Micronized device for the delivery of biologically active molecules and methods of use thereof
|
NZ570614A
(en)
|
2006-01-23 |
2012-07-27 |
Athersys Inc |
Multipotent adult progenitor cell treatment of brain injuries and diseases
|
CA3124132A1
(en)
|
2006-01-23 |
2007-08-02 |
Abt Holding Company |
Mapc therapeutics without adjunctive immunosuppressive treatment
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP2377925A1
(de)
|
2006-04-14 |
2011-10-19 |
Advanced Cell Technology, Inc. |
Haemangiokoloniebildende Zellen
|
US20070255333A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Medtronic, Inc. |
Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
|
US9273356B2
(en)
|
2006-05-24 |
2016-03-01 |
Medtronic, Inc. |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
EP2051726B1
(de)
|
2006-07-18 |
2018-04-18 |
University of Utah Research Foundation |
Verfahren zur behandlung von schmerzen und screening von analgetischen verbindungen
|
US20080039415A1
(en)
*
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
CA2666789C
(en)
*
|
2006-10-18 |
2016-11-22 |
Yong Zhao |
Embryonic-like stem cells derived from adult human peripheral blood and methods of use
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US9375440B2
(en)
*
|
2006-11-03 |
2016-06-28 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
US7988668B2
(en)
*
|
2006-11-21 |
2011-08-02 |
Medtronic, Inc. |
Microsyringe for pre-packaged delivery of pharmaceuticals
|
US7819842B2
(en)
*
|
2006-11-21 |
2010-10-26 |
Medtronic, Inc. |
Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
|
US20080171906A1
(en)
*
|
2007-01-16 |
2008-07-17 |
Everaerts Frank J L |
Tissue performance via hydrolysis and cross-linking
|
WO2008112701A2
(en)
*
|
2007-03-15 |
2008-09-18 |
The Mclean Hospital Corporation |
G-substrate for the treatment and prevention of parkinson's disease
|
EP2134853B1
(de)
|
2007-04-03 |
2018-07-18 |
Oxyrane UK Limited |
Glycosylierung von molekülen
|
ES2476253T3
(es)
|
2007-05-01 |
2014-07-14 |
Biogen Idec Ma Inc. |
P�ptidos de neublastina para su uso en el aumento de la vascularizaci�n en tejido con flujo sanguíneo deteriorado
|
MX2010001993A
(es)
|
2007-08-23 |
2010-03-11 |
Intrexon Corp |
Metodos y composiciones para diagnosticar una enfermedad.
|
WO2009029508A1
(en)
*
|
2007-08-28 |
2009-03-05 |
Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute, Inc. |
Intracranial catheter and methods of use
|
EP2205249B1
(de)
|
2007-09-28 |
2018-11-07 |
Intrexon Corporation |
Therapeutische genschalterkonstrukte und bioreaktoren zur expression biotherapeutischer moleküle und ihre verwendung
|
AU2008309934B2
(en)
|
2007-10-12 |
2014-03-06 |
F. Hoffmann-La Roche Ag |
Protein expression from multiple nucleic acids
|
AU2009205886B2
(en)
|
2008-01-18 |
2015-08-27 |
Katholieke Universiteit Leuven |
Stem cell aggregates and methods for making and using
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
WO2009126655A2
(en)
|
2008-04-07 |
2009-10-15 |
Nupotential, Inc. |
Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
|
WO2009125332A1
(en)
*
|
2008-04-07 |
2009-10-15 |
Peter Bromley |
New and safe procedure for immunization against infectious diseases agents
|
MX2010012088A
(es)
|
2008-05-06 |
2011-07-28 |
Advanced Cell Tech Inc |
Celulas que forman colonias de hemangiomas y celulas de hemangioma sin injertar.
|
AU2009244236B2
(en)
|
2008-05-06 |
2015-03-12 |
Astellas Institute For Regenerative Medicine |
Methods for producing enucleated erythroid cells derived from pluripotent stem cells
|
US8586558B2
(en)
*
|
2008-05-16 |
2013-11-19 |
The Mclean Hospital Corporation |
RAB3B for treatment and prevention of Parkinson's disease
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
EP2195013B1
(de)
|
2008-07-24 |
2011-11-02 |
NsGene A/S |
Therapeutische verwendung eines wachstumsfaktors, metrnl
|
WO2010032242A1
(en)
*
|
2008-09-17 |
2010-03-25 |
Beta O2 Technologies Ltd. |
Optimization of alginate encapsulation of islets for transplantation
|
US9279013B2
(en)
|
2008-10-10 |
2016-03-08 |
Amgen Inc. |
FGF-21 mutants comprising polyethylene glycol and uses thereof
|
WO2010075500A1
(en)
|
2008-12-23 |
2010-07-01 |
Stemcells California, Inc |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
US20120021039A1
(en)
|
2009-01-23 |
2012-01-26 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
AU2010206374B2
(en)
|
2009-01-23 |
2013-01-17 |
Gloriana Therapeutics Sarl |
Improved cell lines and their use in encapsulated cell biodelivery
|
US9511093B2
(en)
|
2009-03-23 |
2016-12-06 |
The Texas A & M University System |
Compositions of mesenchymal stem cells to regenerate bone
|
US20150024024A1
(en)
*
|
2009-04-23 |
2015-01-22 |
Neurotech Usa, Inc. |
Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses Thereof
|
US20120052069A1
(en)
|
2009-05-05 |
2012-03-01 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
CN107188950B
(zh)
|
2009-05-05 |
2021-09-28 |
安姆根有限公司 |
Fgf21突变体及其用途
|
BRPI0902039B8
(pt)
|
2009-06-09 |
2021-05-25 |
Anhanguera Educacional Ltda |
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
|
KR20120089259A
(ko)
|
2009-08-03 |
2012-08-09 |
유니버시티 오브 마이애미 |
T 조절 세포의 생체 내 확장 방법
|
WO2011039634A2
(en)
|
2009-09-29 |
2011-04-07 |
Universiteit Gent |
Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
|
JP2013507373A
(ja)
*
|
2009-10-08 |
2013-03-04 |
ニューロテック ユーエスエー, インコーポレイテッド |
被包された細胞ベースの送達系におけるpedfの使用
|
WO2011061629A2
(en)
|
2009-11-19 |
2011-05-26 |
Oxyrane Uk Limited |
Yeast strains producing mammalian-like complex n-glycans
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
EP2515864A4
(de)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
Vorrichtung mit verzögerter freisetzung
|
EP3940060A1
(de)
|
2010-02-25 |
2022-01-19 |
ABT Holding Company |
Modulierung einer makrophagenaktivierung
|
SG183498A1
(en)
|
2010-02-25 |
2012-09-27 |
Abt Holding Co |
Modulation of angiogenesis
|
EP2558497A2
(de)
|
2010-04-15 |
2013-02-20 |
Amgen Inc. |
Menschlicher fgf-rezeptor und beta-klotho-bindeproteine
|
US9517250B2
(en)
|
2010-04-28 |
2016-12-13 |
The J. David Gladstone Institutes |
Methods for generating cardiomyocytes
|
CA3128483A1
(en)
|
2010-05-12 |
2011-11-17 |
Abt Holding Company |
Modulation of splenocytes in cell therapy
|
WO2011154941A2
(en)
|
2010-06-07 |
2011-12-15 |
Beta-O2 Technologies Ltd. |
Multiple-layer immune barrier for donor cells
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
US9475709B2
(en)
|
2010-08-25 |
2016-10-25 |
Lockheed Martin Corporation |
Perforated graphene deionization or desalination
|
US9689015B2
(en)
|
2010-09-29 |
2017-06-27 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated N-glycans
|
US9347050B2
(en)
|
2010-09-29 |
2016-05-24 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
EP2621512B1
(de)
|
2010-10-01 |
2016-04-06 |
NsGene A/S |
Verwendung von meteorin zur behandlung von allodynie, hyperalgesie, spontanen schmerzen und phantomschmerzen
|
US8815942B2
(en)
|
2010-10-20 |
2014-08-26 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
|
US9539324B2
(en)
|
2010-12-01 |
2017-01-10 |
Alderbio Holdings, Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
US9078878B2
(en)
|
2010-12-01 |
2015-07-14 |
Alderbio Holdings Llc |
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
|
US9884909B2
(en)
|
2010-12-01 |
2018-02-06 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
US11214610B2
(en)
|
2010-12-01 |
2022-01-04 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
|
JP6190723B2
(ja)
|
2010-12-01 |
2017-08-30 |
アルダーバイオ ホールディングス エルエルシー |
抗ngf組成物およびその使用
|
US9067988B2
(en)
|
2010-12-01 |
2015-06-30 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
AU2011336592A1
(en)
|
2010-12-02 |
2013-07-11 |
Neurotech Usa, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
JP6415977B2
(ja)
|
2011-04-15 |
2018-10-31 |
ジェネラックス・コーポレイションGenelux Corporation |
弱毒化ワクシニアウイルスのクローン株およびその使用方法
|
EP3263123A3
(de)
|
2011-06-06 |
2018-05-16 |
Kineta One, LLC |
Pharmazeutische zusammensetzungen auf shk-basis sowie verfahren zu ihrer herstellung und verwendung
|
JP6145667B2
(ja)
|
2011-09-05 |
2017-06-14 |
ホーバ セラピューティクス アンパルトセルスカブ |
アロディニア、痛覚過敏、自発痛、及び幻痛の治療
|
EP3628326B1
(de)
|
2012-03-15 |
2024-02-28 |
Oxyrane UK Limited |
Verfahren und materialien zur behandlung von morbus pompe
|
US9834809B2
(en)
|
2014-02-28 |
2017-12-05 |
Lockheed Martin Corporation |
Syringe for obtaining nano-sized materials for selective assays and related methods of use
|
US9610546B2
(en)
|
2014-03-12 |
2017-04-04 |
Lockheed Martin Corporation |
Separation membranes formed from perforated graphene and methods for use thereof
|
US10118130B2
(en)
|
2016-04-14 |
2018-11-06 |
Lockheed Martin Corporation |
Two-dimensional membrane structures having flow passages
|
US10980919B2
(en)
|
2016-04-14 |
2021-04-20 |
Lockheed Martin Corporation |
Methods for in vivo and in vitro use of graphene and other two-dimensional materials
|
US10376845B2
(en)
|
2016-04-14 |
2019-08-13 |
Lockheed Martin Corporation |
Membranes with tunable selectivity
|
US9744617B2
(en)
|
2014-01-31 |
2017-08-29 |
Lockheed Martin Corporation |
Methods for perforating multi-layer graphene through ion bombardment
|
US10653824B2
(en)
|
2012-05-25 |
2020-05-19 |
Lockheed Martin Corporation |
Two-dimensional materials and uses thereof
|
US20150150796A1
(en)
|
2012-05-30 |
2015-06-04 |
Neurotech Usa, Inc. |
Cryopreserved Implantable Cell Culture Devices and Uses Thereof
|
CA2880808C
(en)
|
2012-08-01 |
2023-01-24 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
EP3492084B1
(de)
|
2012-08-01 |
2021-02-17 |
United Therapeutics Corporation |
Behandlung von lungenarterienhochdruck mit prostacyclinbehandelten endothelvorläuferzellen
|
KR102565827B1
(ko)
|
2013-01-09 |
2023-08-11 |
유니버시티 오브 마이애미 |
TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법
|
ES2697573T3
(es)
|
2013-01-09 |
2019-01-25 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
WO2014136065A2
(en)
|
2013-03-05 |
2014-09-12 |
Oxyrane Uk Limited |
Production of catalytically active type i sulfatase
|
AU2014225352B2
(en)
|
2013-03-07 |
2017-02-09 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device assembly
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
TW201504140A
(zh)
|
2013-03-12 |
2015-02-01 |
Lockheed Corp |
形成具有均勻孔尺寸之多孔石墨烯之方法
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
KR102161726B1
(ko)
|
2013-04-12 |
2020-10-06 |
사베리오 라프란체스카 |
이식용 장기의 개선
|
DK2992088T3
(da)
|
2013-04-30 |
2019-11-11 |
Univ Leuven Kath |
Celleterapi for myelodysplastiske syndromer
|
MX367858B
(es)
|
2013-05-31 |
2019-09-09 |
Univ Utah Res Found |
Péptidos de conotoxina, composiciones farmacéuticas y usos de los mismos.
|
US9572918B2
(en)
|
2013-06-21 |
2017-02-21 |
Lockheed Martin Corporation |
Graphene-based filter for isolating a substance from blood
|
WO2015038669A1
(en)
|
2013-09-11 |
2015-03-19 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
WO2015042580A1
(en)
|
2013-09-23 |
2015-03-26 |
Biogen Idec Ma Inc. |
Compositions and methods for treatment of neuropathic pain
|
WO2015116946A1
(en)
|
2014-01-31 |
2015-08-06 |
Lockheed Martin Corporation |
Perforating two-dimensional materials using broad ion field
|
KR20160142282A
(ko)
|
2014-01-31 |
2016-12-12 |
록히드 마틴 코포레이션 |
다공성 비-희생 지지층을 사용하여 2차원 물질로 복합 구조를 형성하기 위한 프로세스
|
CA2942496A1
(en)
|
2014-03-12 |
2015-09-17 |
Lockheed Martin Corporation |
Separation membranes formed from perforated graphene
|
JP2017534311A
(ja)
|
2014-09-02 |
2017-11-24 |
ロッキード・マーチン・コーポレーション |
二次元膜材料をベースとする血液透析膜および血液濾過膜、ならびにそれを用いた方法
|
EP3188712A1
(de)
*
|
2014-09-04 |
2017-07-12 |
Kemijski Institut |
Zellbasierte vorrichtung zur lokalen behandlung mit therapeutischem protein
|
JP6850734B2
(ja)
|
2015-05-27 |
2021-03-31 |
ニューロテック ユーエスエー, インコーポレイテッド |
眼の障害の処置のためのカプセル化細胞療法の使用
|
AU2016303048A1
(en)
|
2015-08-05 |
2018-03-01 |
Lockheed Martin Corporation |
Perforatable sheets of graphene-based material
|
MX2018001559A
(es)
|
2015-08-06 |
2018-09-27 |
Lockheed Corp |
Modificacion de nanoparticula y perforacion de grafeno.
|
CA3003294A1
(en)
|
2015-10-27 |
2017-05-04 |
The University Of Queensland |
Modified epha4 and uses thereof
|
KR20190018411A
(ko)
|
2016-04-14 |
2019-02-22 |
록히드 마틴 코포레이션 |
그래핀 결함의 선택적 계면 완화
|
WO2017180133A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Methods for in situ monitoring and control of defect formation or healing
|
CA3020686A1
(en)
|
2016-04-14 |
2017-10-19 |
Lockheed Martin Corporation |
Method for treating graphene sheets for large-scale transfer using free-float method
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
AU2017300590A1
(en)
|
2016-07-18 |
2019-01-24 |
Eth Zurich |
B-cell-mimetic cells
|
EP3272877A1
(de)
|
2016-07-18 |
2018-01-24 |
ETH Zurich |
B-zell-mimetische zellen
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
CA3041514A1
(en)
|
2016-10-24 |
2018-05-03 |
United Therapeutics Corporation |
Enhancement of msc immunomodulatory properties by treprostinil
|
JP7088564B2
(ja)
|
2016-11-10 |
2022-06-21 |
ヴィアサイト,インコーポレイテッド |
細胞送達装置におけるpdx1膵臓内胚葉細胞及びその方法
|
CR20190397A
(es)
|
2017-03-10 |
2019-09-27 |
Hoffmann La Roche |
Método para producir anticuerpos multiespecíficos
|
WO2019050633A2
(en)
*
|
2017-07-24 |
2019-03-14 |
California Institute Of Technology |
ELECTRICALLY REMOVABLE, CHEMICALLY AMPLIFIED, LOW-POWERED BARRIER
|
EP3656851A1
(de)
|
2018-11-23 |
2020-05-27 |
Technische Universität Dresden |
Künstliche hla-positive feeder-zelllinien für nk-zellen und verwendungen davon
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
WO2022081760A1
(en)
|
2020-10-14 |
2022-04-21 |
Sana Biotechnology, Inc. |
Hepatocyte-like cells
|
IT202100006569A1
(it)
|
2021-03-18 |
2022-09-18 |
Hemera S R L |
Metodo per ottenere macrofagi rigenerativi educati dal tumore e loro uso nella medicina rigenerativa
|
WO2023081420A1
(en)
|
2021-11-05 |
2023-05-11 |
Abt Holding Company |
Culture-expanded canine progenitor cells and related methods
|
WO2023164171A2
(en)
|
2022-02-25 |
2023-08-31 |
Viacyte, Inc. |
Multilayer implantable cell encapsulation devices and methods thereof
|